Company Monitoring Page for Biogen

latest headlines for company on cafepharma

Significant readouts for small players
EP Vantage
Thu, 03/31/22 - 10:22 am
Tags:
clinical trials, SAGE Therapeutics, Biogen, Relmada, Athira Pharma, TauRx
Biogen Submits Final Plan for Confirmatory Aduhelm Trial
BioSpace
Thu, 03/31/22 - 10:14 am
Tags:
Biogen, Aduhelm, clinical trials, Alzheimer's disease
Chasing Bristol Myers and Biogen/Denali, CNS biotech raises $100M in dash toward clinic
Endpoints
Wed, 03/30/22 - 10:35 am
Tags:
Neuron23, funding, CNS, Bristol Myers Squibb, Biogen, Denali
New blow for ALS pipeline as Biogen and Ionis candidate fails Phase 1 trial
Pharmaforum
Tue, 03/29/22 - 10:54 am
Tags:
Biogen, Ionis Pharmaceuticals, ALS, clinical trials, BIIB078
Biogen, Eisai unveil new data on lecanemab, but questions linger on ARIA-E; Spatial biology outfit grabs $33M round
Endpoints
Tue, 03/22/22 - 11:19 pm
Tags:
Eisai, Biogen, lecanemab, Alzheimer's disease
Ex-Biogen R&D head Sandrock takes the top job at Voyager
Pharmaforum
Tue, 03/22/22 - 10:06 am
Tags:
Voyager Therapeutics, Biogen, Al Sandrock, R&D, Pharma CEOs
Split U.S. appeals court rejects Biogen bid to revive MS drug patent dispute
Reuters
Thu, 03/17/22 - 10:25 am
Tags:
Biogen, Mylan, Tecfidera, patents, multiple sclerosis, MS
Scoop: Biogen will finally publish its PhIII results for Aduhelm
Endpoints
Wed, 03/16/22 - 10:22 am
Tags:
Biogen, Aduhelm, Alzheimer's disease
Biogen jettisons AMD drug, providing Catalyst for ex-partner's hunt for strategic alternatives
Fierce Biotech
Wed, 03/16/22 - 10:10 am
Tags:
Biogen, dry age-related macular degeneration, Catalyst Biosciences, CB 2782-PEG
Eisai hands off responsibility for Aduhelm to Biogen
Pharmaforum
Tue, 03/15/22 - 11:43 am
Tags:
Eisai, Biogen, Aduhelm, Alzheimer's disease
Biogen Announces New Spinraza Data Ahead of Presentation
BioSpace
Mon, 03/14/22 - 11:39 pm
Tags:
Biogen, Spinraza, SMA, spinal muscular atrophy
Alzheimer's patient groups pressure U.S. to pay for Biogen drug
Reuters
Sun, 03/13/22 - 11:07 pm
Tags:
Alzheimer's disease, Biogen, Aduhelm, patient groups
A trio of amyloid-targeted Alzheimer's drugs will soon see key results, but an analyst predicts only 50-50 odds for one
Endpoints
Wed, 03/9/22 - 11:09 pm
Tags:
Alzheimer's disease, clinical trials, Roche, Eli Lilly, Biogen, donanemab, lecanemab, gantenerumab
Biogen's Aduhelm still has blockbuster potential if everything breaks right: analyst
Fierce Pharma
Fri, 03/4/22 - 09:47 am
Tags:
Biogen, Aduhelm, Alzheimer's disease, physicians, analysts
Biogen, struggling to sell Alzheimer's drug, begins layoffs to save money
BioPharma Dive
Thu, 03/3/22 - 12:12 pm
Tags:
Biogen, layoffs, Aduhelm, Alzheimer's disease
3 more deaths among patients on Biogen's Aduhelm fuel safety concerns, though no link established: analyst
Fierce Pharma
Wed, 02/16/22 - 11:19 pm
Tags:
Biogen, Aduhelm, Alzheimer's disease, patient deaths
Sage claims new data show depression drug works, but doubts remain
Biopharma Dive
Wed, 02/16/22 - 11:05 pm
Tags:
SAGE Therapeutics, Biogen, depression, clinical trials, zuranolone
Eli Lilly and Roche ask CMS not to be lumped in with Aduhelm’s restrictive judgment
Endpoints
Mon, 02/14/22 - 11:06 am
Tags:
Eli Lilly, Roche, Biogen, Alzheimer's disease, Aduhelm, CMS
Biogen and Xbrane in deal on rheumatoid arthritis targeting biosimilar
Biopharma Reporter
Mon, 02/14/22 - 11:04 am
Tags:
Biogen, Xbrane Biopharma, monoclonal antibodies, Xcimzane, Cimzia, rheumatoid arthritis
What to Expect From Biogen's $2.3 Billion Shopping Spree
Motley Fool
Sat, 02/12/22 - 11:47 pm
Tags:
Biogen, M&A, Aurinia Pharmaceuticals, Biohaven

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.